Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas. - Wikidata - awgldk - TriplyDB

Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas.

Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas.

http://www.wikidata.org/entity/Q36236573

about

The role of gadoxetic acid as a paramagnetic contrast medium in the characterization and detection of focal liver lesions: a review Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI.Diagnostic Imaging of Hepatocellular Carcinoma - A Pictorial Essay.CT and MRI of primary and metastatic fibrolamellar carcinoma: a case series of 37 patients.Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma MR Imaging of Hepatocellular Adenomas and Differential Diagnosis Dilemma.P4 radiology of hepatobiliary diseases with gadoxetic acid-enhanced MRI as a biomarker.Primary biliary tract malignancies: MRI spectrum and mimics with histopathological correlation.Non-focal liver signal abnormalities on hepatobiliary phase of gadoxetate disodium-enhanced MR imaging: a review and differential diagnosis.A case of hyperfunctioning pancreatic mixed adenoneuroendocrine carcinoma (MANEC) arising from ectopic pancreatic tissue in the liver.Liver-specific contrast agents.Liver perfusion in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI): comparison of enhancement in Gd-BT-DO3A and Gd-EOB-DTPA in normal liver parenchyma.Contrast-enhanced MR cholangiography with Gd-EOB-DTPA for preoperative biliary mapping: correlation with intraoperative cholangiography.

P2860

Q26828543-EE206781-9C1B-4869-9678-1FC501F69E92 Q27016138-BD274223-940C-4882-A3B3-922026F2AC52 Q33668652-1A804011-0247-42BF-9280-F6BFEDAB6085 Q33956249-8FAF06FB-27C6-4A77-BC8E-56A2D3B3CD15 Q35650424-7CBA2592-D481-4CA5-B5A1-F1D9BAB1B672 Q36757993-1074B4D3-4F9F-43E6-A8BB-2143DA0BA0FE Q38177850-9E1E9D5F-4DAB-4079-ACE5-FF1EC30F309F Q38270403-6BE31B39-CCEB-4296-8F4C-7A0B78F8DB85 Q38747328-738796CE-530D-4C87-88B3-377BD06EB5E4 Q41242823-18E18C46-6859-4B9C-B6C4-F9E64EDFD1FE Q41894462-8EB6867A-B146-4F65-B8D3-BE314C91100B Q51129770-A1ADD56B-E9A2-476A-A84C-8E47E99C445E Q53058162-C96A2ED3-2CAE-4662-857F-58BEA7901B86

P2860

Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas.

http://www.wikidata.org/entity/Q36236573

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas.

@ast

Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas.

@en

type

label

Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas.

@ast

Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas.

@en

prefLabel

Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas.

@ast

Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas.

@en

P1433

Q36236573-FA41B6E6-8144-4AEC-A188-FA3169C587A0

P1476

Q36236573-71E0A7D8-2274-48AA-BD89-12A9773416EC

P2093

Q36236573-2D80BABF-1644-47EB-A3ED-D071DE70238A

Q36236573-3B5F1FB4-1022-4211-9C47-814E708E25F2

P2860

Q36236573-19A58F42-BAA1-4B95-A30C-C8F88214E81C

Q36236573-1EB97E63-6237-4A4D-8F9E-0B9C4F567757

Q36236573-31FC246C-AADE-4515-A9A3-49D21575C4A2

Q36236573-3EE6465F-5DF1-423A-B835-8578148CE21E

Q36236573-4C23F534-961B-49FF-9CE1-A27A9B407C49

Q36236573-4E0BAE9D-99C8-44CB-B077-A68D90B1DAE7

Q36236573-5B692A3B-8559-4062-890C-A54354EB9624

Q36236573-67222C85-152D-40D2-92B3-07B68C1836F4

Q36236573-71D45F8E-5AE0-4E3B-A78B-16A9FDD82965

Q36236573-7C8E6010-C317-4AEF-BD4C-F35B9824B488

P2888

Q36236573-C5EF53E3-3221-44BD-8CBF-0147C83E4456

P304

Q36236573-8943E4D2-425B-43B8-9076-873CFE667A6B

P31

Q36236573-C0FF8588-390F-4D4F-8B51-5CA5B90AF8F7

P356

Q36236573-5FF553CB-A161-44BF-8CCB-29A282649A57

P433

Q36236573-9057F2BF-0667-4AE0-931A-B0AE328943CE

P478

Q36236573-753E41A0-56FC-4106-92C2-0DEC17D47B04

P50

Q36236573-E1FBD243-0E0F-4336-AE66-421E5749B152

P577

Q36236573-B24EC7D4-CB72-4261-A80F-6AE6DDC08220

P5875

Q36236573-E9A88551-BE64-4A2F-A374-A0581D1724AA

P698

Q36236573-384255CA-42FF-4928-9B58-6501A51E0250

P932

Q36236573-CE5A7362-DABD-4274-A09E-0D2CC0EBF62C

P356

S13244-012-0179-7

P1433

Insights into imaging

P1476

Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas.

@en

P2093

Jin-Young Choi

http://www.w3.org/2001/XMLSchema#string

José Traila Campos

http://www.w3.org/2001/XMLSchema#string

P2860

Benign hepatic tumors and iatrogenic pseudotumors.

Nontumorous arterioportal shunts in the liver: CT and MRI findings considering mechanisms and fate.

Malignant liver tumors.

Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation.

Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.

MR contrast agents for liver imaging: what, when, how.

Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features.

Magnetic resonance imaging of hepatocellular carcinoma: a pictorial review of novel insights into pathophysiological features revealed by magnetic resonance imaging.

Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation.

Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver.

P2888

s13244-012-0179-7

P304

451-474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13244-012-0179-7

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Claude B. Sirlin

P577

2012-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225374933

http://www.w3.org/2001/XMLSchema#string

P698

22700119

http://www.w3.org/2001/XMLSchema#string

P932

3443279

http://www.w3.org/2001/XMLSchema#string